Allergy Therapeutics PLC Stock
Price
Target price
€0.053
€0.053
-
-
-
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Allergy Therapeutics PLC in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Allergy Therapeutics PLC vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Allergy Therapeutics PLC | - | -7.018% | 15.217% | 783.333% | 146.512% | -80.515% | - |
| Alliance Pharma plc | 0.480% | -4.545% | 0.000% | -23.636% | 3.960% | -64.407% | - |
| Beximco Pharmaceuticals Ltd. GDR | - | 0.000% | -3.167% | 11.458% | -2.727% | -54.947% | -1.835% |
| Cellectar BioSciences Inc. | -3.510% | 2.703% | -14.925% | 28.814% | 0.000% | -78.077% | - |
News
Up Halfway Through 2024, Can AT&T's Stock Continue Its Momentum to Close the Year?
Over the past two decades, the road has been rocky for AT&T (NYSE: T) investors, with the stock price only up close to 5% (not including dividends). This year has been a much-appreciated change of
Can These 2 Ultra-High-Yield Dividend Stocks Outperform the S&P 500 in 2024?
Ultra-high-yield dividend stocks, or companies with annualized payouts above the 5% mark, tend to underperform the broader markets over periods of less than five years. The core reason is that an
Can Retirees Still Trust AT&T's 5.8% Dividend Yield?
U.S. wireless carrier AT&T (NYSE: T) is a polarizing stock among investors. Shares are down nearly 30% in price over the past decade, which is a tough pill to swallow. However, include AT&T's famous